News Agency
Men's Weekly

Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer

  • Written by PR Newswire
Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer

Highlights

  • FDA agreement for a pivotal Phase III trial for 64Cu SAR-bisPSMA diagnostic in prostate cancer 
  • Phase III trial design based on 64Cu SAR-bisPSMA data package, including positive results from the completed PROPELLER trial
  • A total of 383 prostate cancer patients to take part in a pivotal, non-randomised, single-arm,...

Read more: Positive guidance from US FDA on Cu-64 SAR-bisPSMA Phase III trial in prostate cancer

How Headless CMS Enhances Responsive Design and Layout Flexibility

Image by freepik As digital technology continues to evolve at a breakneck pace, users expect much more from content than ever before, and responsive design is crucial to ensure content not only looks but operates across all screens. No longer are... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion